Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide

Leukemia. 2012 Apr;26(4):855-8. doi: 10.1038/leu.2011.268. Epub 2011 Sep 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Blood Transfusion
  • Chromosome Deletion*
  • Chromosomes, Human, Pair 5*
  • Female
  • Humans
  • Lenalidomide
  • Male
  • Myelodysplastic Syndromes / drug therapy
  • Myelodysplastic Syndromes / genetics*
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use

Substances

  • Antineoplastic Agents
  • Thalidomide
  • Lenalidomide